# Oral Carnitine in Heart Failure Patients

> **NCT07201714** · EARLY_PHASE1 · RECRUITING · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 20 (estimated)

## Conditions studied

- Heart Failure
- Carnitine Deficiency

## Interventions

- **DRUG:** Levocarnitine

## Key facts

- **NCT ID:** NCT07201714
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-12
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07201714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07201714, "Oral Carnitine in Heart Failure Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07201714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*